Search

Your search keyword '"Rasmussen CE"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Rasmussen CE" Remove constraint Author: "Rasmussen CE"
39 results on '"Rasmussen CE"'

Search Results

1. Ensembling geophysical models with Bayesian Neural Networks

2. Convergence of sparse variational inference in Gaussian processes regression

3. Overcoming Mean-Field Approximations in Recurrent Gaussian Process Models

4. Data-efficient reinforcement learning in continuous state-action Gaussian-POMDPs

5. Active learning of model evidence using Bayesian quadrature

6. Learning to Control a Low-Cost Manipulator using Data-Efficient Reinforcement Learning

7. PILCO: A Model-Based and Data-Efficient Approach to Policy Search

12. Intratumoral delivery of TransCon ™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction.

13. Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism.

14. TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias.

15. Judging social interaction in the Heider and Simmel movie.

16. Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat.

17. Evaluation of Nonacog Beta Pegol Long-term Safety in the Immune-deficient Rowett Nude Rat (Crl:NIH-Foxn1rnu).

18. Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.

19. Gaussian Processes for Data-Efficient Learning in Robotics and Control.

20. Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease.

21. Holter monitoring of small breed dogs with advanced myxomatous mitral valve disease with and without a history of syncope.

22. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.

23. Radial and longitudinal strain and strain rate assessed by speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.

24. Circulating cytokine concentrations in dogs with different degrees of myxomatous mitral valve disease.

25. Advanced electrocardiographic parameters change with severity of mitral regurgitation in Cavalier King Charles Spaniels in sinus rhythm.

26. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.

27. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.

28. Brain-natriuretic peptide and cyclic guanosine monophosphate as biomarkers of myxomatous mitral valve disease in dogs.

29. Holter monitoring in clinically healthy Cavalier King Charles Spaniels, Wire-haired Dachshunds, and Cairn Terriers.

30. Evaluation of plasma and urinary levels of 6-keto-prostaglandin F1alpha as a marker for asymptomatic myxomatous mitral valve disease in dogs.

31. Modeling and visualizing uncertainty in gene expression clusters using dirichlet process mixtures.

32. Surface tension of quantum fluids from molecular simulations.

33. Clustering protein sequence and structure space with infinite Gaussian mixture models.

34. Perfusion quantification using Gaussian process deconvolution.

35. Twelve years' clinical experience with the CarboMedics prosthetic heart valve.

36. Presynaptic and postsynaptic competition in models for the development of neuromuscular connections.

37. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.

Catalog

Books, media, physical & digital resources